incretin mimetics glp 1 agonists Frontiers Incretin Therapeutics in the Management
Description
In individuals with T2DM undergoing intensive glycemic control, exenatide treatment significantly increased nerve regeneration and improved the severity of pain [88]
Food and Drug Administration (FDA) in 2011
Diabetes Obesity and Metabolism
Diz-Chaves, Y
In addition, the glucagon part may also help reduce fat in the liver, which is important for NASH studies
Available from: 57
